IMCC
Im Cannabis Corp
NASDAQ · Pharmaceuticals
$1.15
+0.02 (+1.77%)
Open$1.10
Previous Close$1.13
Day High$1.24
Day Low$1.10
52W High$2.97
52W Low$1.95
Volume—
Avg Volume703.0K
Market Cap13.11M
P/E Ratio18.42
EPS$0.15
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+207.8% upside
Current
$1.15
$1.15
Target
$3.54
$3.54
$2.21
$3.54 avg
$4.26
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.19M | 4.60M | 5.55M |
| Net Income | 706.3K | 612.3K | 695.3K |
| Profit Margin | 13.6% | 13.3% | 12.5% |
| EBITDA | 1.03M | 960.1K | 1.02M |
| Free Cash Flow | 306.9K | 405.9K | 317.4K |
| Rev Growth | +20.5% | +11.5% | +14.8% |
| Debt/Equity | 0.67 | 0.89 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |